These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Tolerability of three selective cyclo-oxygenase-2 inhibitors, meloxicam, celecoxib and rofecoxib in NSAID-sensitive patients. Senna G; Bilò MB; Antonicelli L; Schiappoli M; Crivellaro MA; Bonadonna P; Dama AR Eur Ann Allergy Clin Immunol; 2004 Jun; 36(6):215-8. PubMed ID: 15329003 [TBL] [Abstract][Full Text] [Related]
3. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect? Geis GS Scand J Rheumatol Suppl; 1999; 109():31-7. PubMed ID: 10422544 [TBL] [Abstract][Full Text] [Related]
4. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. Silverstein FE; Faich G; Goldstein JL; Simon LS; Pincus T; Whelton A; Makuch R; Eisen G; Agrawal NM; Stenson WF; Burr AM; Zhao WW; Kent JD; Lefkowith JB; Verburg KM; Geis GS JAMA; 2000 Sep; 284(10):1247-55. PubMed ID: 10979111 [TBL] [Abstract][Full Text] [Related]
5. Biochemical and clinical evidence that aspirin-intolerant asthmatic subjects tolerate the cyclooxygenase 2-selective analgetic drug celecoxib. Gyllfors P; Bochenek G; Overholt J; Drupka D; Kumlin M; Sheller J; Nizankowska E; Isakson PC; Mejza F; Lefkowith JB; Dahlén SE; Szczeklik A; Murray JJ; Dahlén B J Allergy Clin Immunol; 2003 May; 111(5):1116-21. PubMed ID: 12743579 [TBL] [Abstract][Full Text] [Related]
6. Celecoxib, a selective cyclooxygenase-2 inhibitor for the treatment of rheumatoid arthritis and osteoarthritis. Goldenberg MM Clin Ther; 1999 Sep; 21(9):1497-513; discussion 1427-8. PubMed ID: 10509845 [TBL] [Abstract][Full Text] [Related]
7. A comparison of renal-related adverse drug reactions between rofecoxib and celecoxib, based on the World Health Organization/Uppsala Monitoring Centre safety database. Zhao SZ; Reynolds MW; Lejkowith J; Whelton A; Arellano FM Clin Ther; 2001 Sep; 23(9):1478-91. PubMed ID: 11589261 [TBL] [Abstract][Full Text] [Related]
8. The hepatic safety and tolerability of the novel cyclooxygenase-2 inhibitor celecoxib. Maddrey WC; Maurath CJ; Verburg KM; Geis GS Am J Ther; 2000 May; 7(3):153-8. PubMed ID: 11317164 [TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory and upper gastrointestinal effects of celecoxib in rheumatoid arthritis: a randomized controlled trial. Simon LS; Weaver AL; Graham DY; Kivitz AJ; Lipsky PE; Hubbard RC; Isakson PC; Verburg KM; Yu SS; Zhao WW; Geis GS JAMA; 1999 Nov; 282(20):1921-8. PubMed ID: 10580457 [TBL] [Abstract][Full Text] [Related]
10. What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective. Hochberg MC Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S15-22. PubMed ID: 11695246 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the baseline cardiovascular risk profile among hypertensive patients prescribed COX-2-specific inhibitors or nonspecific NSAIDs: data from real-life practice. Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC Am J Manag Care; 2002 Oct; 8(15 Suppl):S392-400. PubMed ID: 12416789 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy and tolerability of dexibuprofen and celecoxib in the treatment of osteoarthritis of the hip. Hawel R; Klein G; Singer F; Mayrhofer F; Kähler ST Int J Clin Pharmacol Ther; 2003 Apr; 41(4):153-64. PubMed ID: 12708604 [TBL] [Abstract][Full Text] [Related]
13. Celecoxib versus diclofenac and omeprazole in reducing the risk of recurrent ulcer bleeding in patients with arthritis. Chan FK; Hung LC; Suen BY; Wu JC; Lee KC; Leung VK; Hui AJ; To KF; Leung WK; Wong VW; Chung SC; Sung JJ N Engl J Med; 2002 Dec; 347(26):2104-10. PubMed ID: 12501222 [TBL] [Abstract][Full Text] [Related]
14. Celecoxib, a highly selective COX-2 inhibitor, is safe in aspirin-induced asthma patients. Martín-García C; Hinojosa M; Berges P; Camacho E; García-Rodriguez R; Alfaya T J Investig Allergol Clin Immunol; 2003; 13(1):20-5. PubMed ID: 12861847 [TBL] [Abstract][Full Text] [Related]
15. Interaction of rofecoxib and celecoxib with warfarin. Schaefer MG; Plowman BK; Morreale AP; Egan M Am J Health Syst Pharm; 2003 Jul; 60(13):1319-23. PubMed ID: 12901032 [TBL] [Abstract][Full Text] [Related]
16. Cost of heart failure among hypertensive users of nonspecific NSAIDs and COX-2-specific inhibitors. Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC Am J Manag Care; 2002 Oct; 8(15 Suppl):S414-27. PubMed ID: 12416791 [TBL] [Abstract][Full Text] [Related]
17. Arthritis. Should you be taking a COX-2 inhibitor? Harv Health Lett; 2001 Nov; 27(1):1-3. PubMed ID: 11724695 [No Abstract] [Full Text] [Related]
18. Reporting of 6-month vs 12-month data in a clinical trial of celecoxib. Wright JM; Perry TL; Bassett KL; Chambers GK JAMA; 2001 Nov; 286(19):2398-400. PubMed ID: 11712925 [No Abstract] [Full Text] [Related]
19. Reporting of 6-month vs 12-month data in a clinical trial of celecoxib. Hrachovec JB; Mora M JAMA; 2001 Nov; 286(19):2398; author reply 2399-400. PubMed ID: 11712924 [No Abstract] [Full Text] [Related]